Shandong Weigao Blood Purification Products Co (SHSE:603014) Other Current Payables: ¥331 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
39 GF Score
Price ¥33.87
! 3 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Other Current Payables?

Shandong Weigao Blood Purification Products Co SHSE:603014 -0.67% 39 Other Current Payables is ¥331 Mil as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 39/100. The stock has 3 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥331 Mil.

Shandong Weigao Blood Purification Products Co's quarterly Other Current Payables declined from Sep. 2025 (¥452 Mil) to Dec. 2025 (¥369 Mil) and declined from Dec. 2025 (¥369 Mil) to Mar. 2026 (¥331 Mil).

Shandong Weigao Blood Purification Products Co's annual Other Current Payables increased from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥371 Mil) but then declined from Dec. 2024 (¥371 Mil) to Dec. 2025 (¥369 Mil).

Shandong Weigao Blood Purification Products Co Other Current Payables Related Terms

Shandong Weigao Blood Purification Products Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Other Current Payables Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 534.63 514.52 0.00 371.39 369.20

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 330.27 320.85 452.14 369.20 331.21
SHSE:603014
39GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥331 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Other Current Payables of ¥331 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Other Current Payables too high?
Shandong Weigao Blood Purification Products Co's current Other Current Payables is ¥331 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Other Current Payables compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Other Current Payables of ¥331 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Other Current Payables is ¥331 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Other Current Payables of ¥331 Mil. The current Other Current Payables is ¥331 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Other Current Payables is ¥331 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
39GF Score

Get the complete analysis for SHSE:603014

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.87
Price